期刊文献+

盘状结构域受体酪氨酸激酶1与炎症关系的研究进展 被引量:3

Advances in the Study of the Relationship between Discoidin Domain Receptor Tyrosine Kinases 1 and Inflammation
下载PDF
导出
摘要 盘状结构域受体酪氨酸激酶1(DDR1)是新发现的一种受体酪氨酸激酶,可以与其配体——胶原蛋白特异性结合,而这种结合可导致位于胞内区的酪氨酸激酶缓慢而持续的磷酸化,这种磷酸化可参与细胞的增殖、分化、黏附、迁移以及炎症信号通路的活化,进而导致多种病理学的改变,如纤维化和恶性肿瘤的发生、发展。同时,DDR1还可参与多个脏器的炎症反应,如肝炎、肾炎、中枢神经系统炎症等。未来,需进一步研究DDR1是否参与其他脏器的炎症反应,力求全面反映DDR1在炎症中所发挥的作用。 Discoidin domain receptor tyrosine kinases 1 ( DDR1 ) is a newly discovered type of receptor tyrosine kinase, and can specially bind a number of different native collagen types. This binding leads to slow and continuous phosphorylation of tyrosine kinases located in the intraeeilular part of the receptor, involved in cell proliferation, differentiation, adhesion, migration and activation of the inflammation signal pathway, which are involved in a variety of pathological changes such as fibrosisand the occurrence and development of malignant tumors. In addition, DDR1 is 'also involved in inflammatory reac- tions of multiple organs, such as hepatitis, nephritis, central nervous system inflammation, etc. In the future, further study on whether DDR1 is involved in the inflammatory response of other organs still needed, so as to fully reflect the role of DDR1 in inflammation.
作者 郭丽芳 尚琪 张翠霞 温萌 张德奎 GUO Lifang SHANG Qi ZHANG Cuixia WEN Meng ZHANG Dekui.(Department of Gastroenterology, the Second Hospital of Lanzhou University,Lanzhou 730000, Chin)
出处 《医学综述》 2017年第18期3546-3550,共5页 Medical Recapitulate
基金 国家自然科学基金(81470808)
关键词 盘状结构域受体酪氨酸激酶1 受体酪氨酸激酶 炎症反应 Discoidin domain receptor tyrosine kinases 1 Receptor tyrosine kinases Inflammation
  • 相关文献

参考文献4

二级参考文献67

  • 1Matsuyama W, Watanabe M, Shirahama Y, et al. Suppression of discoidin domain receptor 1 by RNA interference attenuates lung inflammation. J Immunol, 2006, 176 (3) : 1928 - 1936.
  • 2Vogel WF, Abdulhussein R, Ford CE. Sensing extracellular matrix : an update on discoidin domain receptor function. Cell Signal, 2006, 18(8) :1108 -1116.
  • 3Tiegs G, Hentschel J, Wendel A. A T cell - dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest, 1992, 90 ( 1 ) : 196 - 203.
  • 4Kumar LD, Clarke AR. Gene manipulation through the use of small interfering RNA (siRNA) : From in vitro to in vivo applications. Adv Drug Deliv Rev, 2007, 59 (2 - 3 ) :87 - 100.
  • 5Peng J, Zhao Y, Mai J, et al. Inhibition of hepatitis B virus replication by various RNAi constructs and their pharmacodynamic properties. J Gen Virol, 2005, 86 (Pt 12) :3227 -3234.
  • 6Wesche- Soldato DE, Chung CS, Lomas- Neira J, et al. In vivo delivery of caspase - 8 or Fas siRNA improves the survival of septic mice. Blood, 2005, 106(7) :2295 -2301.
  • 7Mizuhara H, O Neill E, Seki N, et al. T cell activation -associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med, 1994, 179(5) :1529 -1537.
  • 8Gantner F, Leist M, Lohse AW, et al. Coneanavalin A - induced T - cell - mediated hepatic injury in mice : the role of tumor necrosis factor. Hepatology, 1995, 21 ( 1 ) :190 - 198.
  • 9Dong Z, Wei H, Sun R, et al. The roles of innate immune cells in liver injury and regeneration. Cell Mol Immunol, 2007, 4(4) : 241 - 252.
  • 10Matsuyama W, Mitsuyama H, Ono M, et al. Discoidin domain receptor 1 contributes to eosinophil survival in an NF - kappaB - dependent manner in Churg - Strauss syndrome. Blood, 2007, 109 (1) :22 -30.

共引文献12

同被引文献11

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部